124
Views
10
CrossRef citations to date
0
Altmetric
Review

Management of cardiovascular disease in Turner syndrome

&
Pages 1631-1641 | Published online: 10 Jan 2014

References

  • Sybert VP, McCauley E. Turner’s syndrome. N. Engl. J. Med.351(12), 1227–1238 (2004).
  • Hjerrild BE, Havmand Mortensen K, Gravholt CH. Turner syndrome and clinical treatment. Br. Med. Bull.86, 77–93 (2008).
  • Ostberg JE, Brookes JAS, McCarthy C, Halcox J, Conway GS. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J. Clin. Endocrinol. Metab.89(12), 5966–5971 (2004).
  • Boucher CA, Sargent CA, Ogata T, Affara NA. Breakpoint analysis of Turner patients with partial Xp deletions: implications for the lymphoedema gene location. J. Med. Genet.38, 591–598 (2001).
  • Day G, Szvetko A, Griffiths L et al.SHOX gene is expressed in vertebral body growth plates in idiopathic and congenital scoliosis: implications for the etiology of scoliosis in Turner syndrome. J. Orthop. Res.27(6), 807–813 (2009).
  • Mazzanti L, Cacciari E. Congenital heart disease in patients with Turner’s Syndrome. J. Pediatrics133(5), 688–692 (1998).
  • Völkl TM, Degenhardt K, Koch A, Simm D, Dörr HG, Singer H. Cardiovascular anomalies in children and young adults with Ullrich–Turner syndrome the Erlangen experience. Clin. Cardiol.28(2), 88–92 (2005).
  • Sybert VP. Cardiovascular malformations and complications in Turner syndrome. Pediatrics101(1), 1–7 (1998).
  • Gotsche CO, Krag-Olsen B, Nielsen J, Sorenson KE, Kristensen BO. Prevalence of cardiovascular malformations and association with karyotypes in Turner’s syndrome. Arch. Dis. Child.71, 433–436 (1994).
  • Reis PM, Punch MR, Bove EL, Van De Ven CJ. Outcome of infants with hypoplastic left heart and Turner syndromes. Obstet. Gynencol.93(4), 532–535 (1999).
  • Van Egmond H, Orye E, Praet M, Coppens M, Devloo-Blancquaert A. Hypoplastic left heart syndrome and 45X karyotype. Br. Heart J.60(1), 69–71 (1988).
  • Ho VB, Bakalov VK, Cooley M et al. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation110, 1694–1700 (2004).
  • Douchin S, Rossignol AM, Klein SK, Siché JP, Baguet JP, Bost M. Heart malformations and vascular complications associated with Turner’s syndrome. Prospective study of 26 patients. Arch. Mal Coeur Vaiss.93(5), 565–570 (2000).
  • Sachdev V, Matura LA, Sidenko S et al. Aortic valve disease in Turner syndrome. J. Am. Coll. Cardiol.51(19), 1904–1909 (2008).
  • Andersen NH, Hjerrild BE, Sorensen K et al. Sublinical left ventricular dysfunction in normotensive women with Turner syndrome. Heart92, 1516–1517 (2006).
  • Sozen AB, Cefle K, Kudat H et al. Left ventricular thickness is increased in nonhypertensive Turner’s syndrome. Echocardiography.26(8), 943–949 (2009).
  • Clark EB. Neck web and congenital heart defects: a pathogenic association in 45 X-O Turner syndrome? Teratology29, 355–361 (1984).
  • Anisimov A, Alitalo A, Korpisalo P et al. Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle. Circ. Res. (104), 1302–1312 (2009).
  • Brandenberg H, Steegers EA, Gittenberger-de-Groot AC. Potential involvement of vascular endothelial growth factor in pathophysiology of Turner syndrome. Med. Hypotheses65(2), 300–304 (2005).
  • Massa G, Verlinde F, De Schepper J et al. Trends in age at diagnosis of Turner syndrome. Arch. Dis. Child.90, 267–268 (2005).
  • Gravholt CH. Turner syndrome in adulthood. Horm. Res.64(2), 86–93 (2005).
  • Stochholm K, Juul S, Knud J, Naeraa RW, and Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J. Clin. Endocrin. Metab.91(10), 3897–3902 (2006).
  • Ravelo HR, Stephenson LW, Friedman S et al. Coarctation resection in children with Turner’s syndrome: a note of caution. J. Thorac. Cardiovasc. Surg.80(3), 427–430 (1980).
  • Badmanaban B, Mole D, Sarsam MA. Descending aortic dissection post coarctation repair in a patient with Turner’s syndrome. J. Card. Surg.18(2), 153–154 (2003).
  • Fejzic Z, van Oort. Fatal dissection of the descending aorta after implantation of a stent in a 19 year old female with Turner syndrome. Cardiol. Young15, 529–531 (2005).
  • Prandstraller D, Mazzanti L, Picchio FM et al. Turner’s syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-up of 136 nonpreselected patients. Pediatr. Cardiol.20(2), 108–112 (1999).
  • Ammash NM, Seward JB, Warnes CA et al. Partial anomalous pulmonary venous connection: diagnosis by transesophageal echocardiography. J. Am. Coll. Cardiol.29, 1351–1358 (1997).
  • Gravholt CH, Landin-Wilhelmsen K, Stochholm K et al. Clinical and epidemiological description of aortic dissection in Turner’s syndrome. Cardiol. Young16, 430–436 (2006).
  • Russo CF, Cannata A, Lanfranconi M, Vitali E, Garatti A, Bonacina E. Is aortic wall generation related to bicuspid aortic valve anatomy in patients with valvular disease? J. Thorac. Cardiovasc. Surg.36(4), 937–942 (2008).
  • Yetman AT, Graham T. The dilated aorta in patients with congenital cardiac defects. J. Am. Coll. Card.53(6), 461–467 (2009).
  • Matura LA, Ho VB, Rosing DR, Bondy CA. Aortic dilation and dissection in Turner syndrome. Circulation116(5), 1663–1670 (2007).
  • Lopez L, Arheart KL, Colan SD et al. Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics (121), e1622–e1627 (2008).
  • Dulac Y, Pienkowski C, Abadir S, Tauber M, Acar P. Cardiovascular abnormalities in Turner’s syndrome: what prevention? Arch. Cardiovasc. Dis.101(7–8), 485–490 (2008).
  • Carlson M, Silberbach M. Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature. J. Med. Genet. (44), 745–749 (2007).
  • Gravholt CH, Hansen KW, Erlandsen M, Ebbehoj E, Christiansen JS. Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J. Hypertens.24(2), 353–360 (2006).
  • Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol.78(6), 539–552 (2009).
  • Golledge J, Clancy P, Jamrozik K, Norman PE. Obesity, adopokines and abdominal aortic aneurysm: health in men study. Circulation116, 2275–2279 (2007).
  • Karakaya O, Barutcu I, Esen AM et al. Relationship between circulating plasma matrix metalloproteinase-9 (gelatinase B) concentration and aortic root dilation. Am. J. Hypertens.19(4), 361–365 (2006).
  • Yetman AT, McCrindle BW. The impact of obesity in patients with Marfan syndrome. Can. J. Cardiol. (2010) (In Press).
  • Mortensen K, Aydin MA, Rybczynski M et al. Augmentation index relates to progression of aortic disease in adults with Marfan syndrome. Am. J. Hypertens.22(9), 971–979 (2009).
  • Grotenhuis HB, Ottenkamp J, Westenberg JJ, Bax JJ, Kroft LJ, deRoos A. Reduced aortic elasticity and dilatation are associated with aortic regurgitation and left ventricular hypertrophy in nonstenotic bicuspid aortic valve patients. J. Am. Coll. Cardiol.49(15), 1660–1665 (2007).
  • Van den Berg J, Bannink EM, Wielopolski PA, Pattynama PM, de Muinck Keizer-Schrama SM, Helbing WA. Aortic distensibility and dimensions and the effects of growth hormone treatment in the Turner syndrome. Am. J. Cardiol.97(11), 1644–1649 (2006).
  • Baguet JP, Douchin S, Pierre H, Rossignol AM, Bost M, Mallion JM. Stuctural and functional abnormalities of large arteries in the Turner syndrome. Heart9, 1442–1446 (2005).
  • Ostberg JE, Donald AE, Halcox JPJ, Storry C, McCarthy C, Conway GS. Vasculopathy in Turner syndrome: arterial dilatatioin and intimal thickening without endothelial dysfunction. J. Clin. Endocrinol. Metab.90(9), 5161–5166 (2005).
  • Kaelba DC, Pickett F. Simple table to identify children and adolescents needing further evaluation of blood pressure. Pediatrics123(6), 297–304 (2009).
  • Virdis R, Cantu MC, Ghizzoni L et al. Blood pressure behaviour and control in Turner syndrome. Clin. Exp. Hypertens. A8(405), 787–791 (1986).
  • Lichiardopol C, Mota M, Braicu D, Militaru C, Mixich F. Diabetes mellitus and Turner syndrome. Rom. J. Intern. Med.45(3), 299–304 (2007).
  • Ding EL, Song Y, Manson JE et al. Sex hormone-binding globulin and risk of Type 2 diabetes in women and men. N. Engl. J. Med. (2009) (Epub ahead of print).
  • Bakalov VK, Cheng C, Zhou J, Bondy CA. X-chormosome gene dosage and the risk of diabetes in Turner syndrome. J. Clin. Endocrinol. Metab.94(9), 3289–3296 (2009).
  • Ross JL, Feuillan P, Long LM, Kowal K, Kushner H, Cutler GB. Lipid abnormalities in Turner syndrome. J. Pediatr.126(2), 242–245 (1995).
  • Oya ID, Schoppen S, Lasunción MA et al. Sex hormone-binding globulin levels and metabolic syndrome and its features in adolescents. Pediatr. Diabetes DOI: 10.1111/j.1399-5448.2009.00559.x (2009).
  • Bondy CA. Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group. J. Clin. Endocrin. Metab.92(1), 10–25 (2007).
  • El-Mansoury M, Berntorp K, Bryman I. Elevated liver enzymes in Turner syndrome during a 5-year follow-up study. Clin. Endocrinol.68(3), 485–490 (2008).
  • Dalla Pozza R, Bechtold S, Urschel S, Netz H, Schwarz HP. QTc interval prolongation in children with Turner syndrome: the results of exercise testing and 24-h ECG. Eur J. Pediatr.168(1), 59–64 (2009).
  • Swerdlow AJ, Hermon C, Jacobs PA et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann. Hum. Genet.65, 177–188 (2001).
  • Aligeti VR, Horn HR. Turner’s syndrome and coronary artery disease. Am. J. Cardiol.99(5), 741–742 (2007).
  • Komori H, Matsuishi T, Abe T et al. Turner syndrome and occlusion of the internal carotid artery. J. Child. Neurol.8(4), 412–415 (1993).
  • Shoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA; United Kingdom Clinical Cytogenetics Group. Mortality in women with Turner syndrome in Great Britain: a national cohort study. J. Clin. Endocrinol. Metab.93(12), 4735–4742 (2008).
  • Bondy CA, Ceniceros I, Van PL, Bakalov K, Rosing DR. Prolonged Rate-corrected QT interval and other electrocardiogram abnormalities in girls with Turner Syndrome. Pediatrics118(4), 1220–1225 (2006).
  • Sozen AB, Cefle K, Kudat H et al. Atrial and ventricular arryhthmogenic potential in Turner Syndrome. Pacing Clin. Electrophysiol.31(9), 1140–1145 (2008).
  • The practice committee of the American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil. Steril. (83), 1074–1075 (2005).
  • Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA288(3), 321–333 (2002).
  • Harman M, Naftolin F, Brinton EA, Judelson DR. Is the estrogen controversy over? Deconstructing the Women’s Health Initiative study: a critical evaluation of the evidence. Ann. NY Acad. Sci.1052, 43–56 (2005).
  • Harman SM, Brinton EA, Cedars M et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric8(1), 3–12 (2005).
  • Elsheikh M, Conway GS. The impact of obesity on cardiovascular risk factors in Turner’s syndrome. Clin. Endocrinol.49(4), 447–450 (1998).
  • Langrish JP, Mills NL, Bath LE. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension53(5), 805–811 (2009).
  • Koulouri O, Ostberg J, Conway GS. Liver dysfunction in Turner’s syndrome: prevalence, natural history and effect of exogenous oestrogen. Clin. Endocrinol.69(2), 306–310 (2008).
  • Bannink EM, van der Palen RL, Mulder PG, de Muick Keizer-Schrama SM. Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences. Horm. Res.71(6), 343–349 (2009).
  • Bondy CA, Van PL, Bakalov VK, Ho VB. Growth hormone treatment and aortic dimensions in Turner syndrome. J. Clin. Endocrinol. Metab.91(5), 1785–1788 (2006).
  • Bondy CA, Bakalov VK, Lange ED, Ceniceros I. Deficient medical care for adults with the Turner syndrome. Ann. Int. Med.145(11), 866–867 (2006).
  • Devernay M, Ecosse E, Coste J, Carel JC. Determinants of medical care for young women with Turner syndrome. J. Clin. Endocrinol. Metab. (2009) (Epub ahead of print).
  • Zuckerman-Levin N, Zinder O, Greenberg A, Levin M, Jacob G, Hochberg Z. Physiological and catecholamine response to sympathetic stimulation in Turner syndrome. Clin. Cendocrinol.64(4), 410–415 (2006).
  • Gordon KJ, Blobe GC. Role of transforming growth factor beta superfamily signaling pathways in human disease. Biochemica Biophysica. Acta1782, 197–228 (2008).
  • Davies RR, Gallo A, Coady MA et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann. Thorac. Surg.81(1), 169–177 (2006).
  • Parish LM, Gorman JH, Kahn S et al. Aortic size in acute type A dissection: implications for preventive ascending aortic replacement. Eur. J. Cardiothorac. Surg.35(6), 941–945 (2009).
  • Orliaguet O, Pepin JL, Bettega G, Ferretti G, Mignotte HN, Levy P. Sleep apnoea and Turner’s syndrome. Eur. Resp. J.17, 153–155 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.